Recent oral contraceptive use by formulation and breast cancer risk among women 20 to 49 years of age.
about
Reproduction and breast cancer riskUse of exogenous hormones and the risk of breast cancer: results from self-reported survey data with validity assessment.Oral contraceptives cause evolutionarily novel increases in hormone exposure: A risk factor for breast cancer.A case-control analysis of oral contraceptive use and breast cancer subtypes in the African American Breast Cancer Epidemiology and Risk Consortium.Metabolomics reveals impaired maturation of HDL particles in adolescents with hyperinsulinaemic androgen excess.Cancer incidence attributable to the use of oral contraceptives and hormone therapy in Alberta in 2012.Safety of medical treatments for endometriosis.Hormonal contraception and breast cancer, what more do we need to know?Contraception for the perimenopausal woman.State of the evidence 2017: an update on the connection between breast cancer and the environmentThe impact of combined oral contraceptives on ocular tissues: a review of ocular effects.Translational opportunities for broad-spectrum natural phytochemicals and targeted agent combinations in breast cancer.Does levonorgestrel-releasing intrauterine system increase breast cancer risk in peri-menopausal women? An HMO perspective.Progestin-only and combined oral contraceptives and receptor-defined premenopausal breast cancer risk: The Norwegian Women and Cancer Study.Epidemiology, Lifestyle, and Environmental FactorsHormonal Contraception and Breast Cancer Risk
P2860
Q26864320-35798CDE-3F30-4CB7-99D1-684BFC00359FQ31032088-865E80AA-7BBE-4F19-BCC6-A223B3BF8E54Q33862767-EA1574B5-E9A0-4776-8987-0515BE811367Q35174900-629F2689-B1A1-4577-AE7A-DD110E55DD77Q35671062-FC1710B0-4B65-4A23-8ACB-E6FBA673AFF8Q37520988-C34EE8AA-E790-463C-9A01-5FB3ACDEC106Q38635759-BF884148-8C4F-4608-BE4D-E77411431EB9Q38714408-CA9B2198-AACF-40EE-A049-E6E2902C3B1EQ38964244-3F2F9D2D-80F6-4EE3-827A-19025BED947EQ41595188-A9FCFB39-0E1F-4DD1-B9D2-9F939AEEC42EQ45399966-4D4D91E0-66A6-4ED1-850A-3665ED126583Q47567895-E60B82E0-B9C7-49CF-BE86-0E6AFE6AAAB5Q47638270-3569AB33-D1B8-44FA-A8AF-843734CDF01BQ48212165-1605D24B-2567-46B6-ADB6-46B7917E0333Q56779064-8465C675-27FA-4669-8E85-5C6CC6EDF36FQ57114802-BA48001E-D43B-476D-9388-D449B9365E19
P2860
Recent oral contraceptive use by formulation and breast cancer risk among women 20 to 49 years of age.
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Recent oral contraceptive use ...... g women 20 to 49 years of age.
@ast
Recent oral contraceptive use ...... g women 20 to 49 years of age.
@en
Recent oral contraceptive use ...... g women 20 to 49 years of age.
@nl
type
label
Recent oral contraceptive use ...... g women 20 to 49 years of age.
@ast
Recent oral contraceptive use ...... g women 20 to 49 years of age.
@en
Recent oral contraceptive use ...... g women 20 to 49 years of age.
@nl
prefLabel
Recent oral contraceptive use ...... g women 20 to 49 years of age.
@ast
Recent oral contraceptive use ...... g women 20 to 49 years of age.
@en
Recent oral contraceptive use ...... g women 20 to 49 years of age.
@nl
P2093
P2860
P1433
P1476
Recent oral contraceptive use ...... g women 20 to 49 years of age.
@en
P2093
Christopher I Li
Diana S M Buist
Elisabeth F Beaber
Kathleen E Malone
Susan D Reed
William E Barlow
P2860
P304
P356
10.1158/0008-5472.CAN-13-3400
P407
P577
2014-08-01T00:00:00Z